Equities

Aspen Aerogels Inc

Aspen Aerogels Inc

Actions
IndustrialsConstruction and Materials
  • Price (USD)24.88
  • Today's Change0.600 / 2.47%
  • Shares traded1.40m
  • 1 Year change+317.45%
  • Beta2.1782
Data delayed at least 15 minutes, as of Sep 19 2024 00:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Consensus recommendation

  • 14-Sep-23
  • 20-Jun-24
  • 18-Jul-24
  • 15-Aug-24
  • 12-Sep-24
Select bar for recommendation details.
Recommendations12-Sep-24
Buy1
Outperform10
Hold0
Sell0
Strong Sell0

Share price forecast in USD

The 11 analysts offering 12 month price targets for Aspen Aerogels Inc have a median target of 35.00, with a high estimate of 41.00 and a low estimate of 14.00. The median estimate represents a 40.68% increase from the last price of 24.88.
High64.8%41.00
Med40.7%35.00
Low-43.7%14.00

Earnings history & estimates in USD

On Aug 07, 2024, Aspen Aerogels Inc reported 2nd quarter 2024 earnings of 0.21 per share. This result exceeded the 0.05 consensus of the 9 analysts covering the company and outperformed last year's 2nd quarter results by 0.43.
The next earnings announcement is expected on Oct 30, 2024.
Average growth rate+2.79%
Aspen Aerogels Inc reported annual 2023 losses of -0.66 per share on Feb 12, 2024.
Average growth rate-21.98%
More ▼

Revenue history & estimates in USD

Aspen Aerogels, Inc. had 2nd quarter 2024 revenues of 117.77m. This bettered the 101.43m consensus of the 9 analysts covering the company. This was 158.35% above the prior year's 2nd quarter results.
Average growth rate+25.40%
Aspen Aerogels, Inc. had revenues for the full year 2023 of 238.72m. This was 32.35% above the prior year's results.
Average growth rate+18.47%
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.